SCHEMBL2073567

SCHEMBL2073567

CC(C)c1ccc([S+]([O-])c2ccccc2C(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DHODH Q02127 1/20 0.41
ALDH1A1 P00352 3/20 0.38
ALOX15 P16050 1/20 0.38
HPGD P15428 1/20 0.38
XBP1 P17861 1/20 0.38
MCL1 Q07820 1/20 0.37
MAPT P10636 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
KAT6A Q92794 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CNR2 P34972 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12772116 0.84 ALDH1A1 (0.49) KMT2AALDH1A1ALOX15HPGDXBP1
SCHEMBL506130 0.84 ALDH1A1 (0.50) SMN1; SMN2L3MBTL1ALDH1A1ALOX15HPGD
SCHEMBL30828909 0.78 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1ALOX15HPGDMAPT
SCHEMBL2573164 0.78 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1ALOX15HPGDMAPT
SCHEMBL27707182 0.77 FOLH1 (0.41) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL9133437 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1ALOX15HPGDMAPT
SCHEMBL9132558 0.76 ALDH1A1 (0.54) RAB9ASMN1; SMN2ALDH1A1ALOX15HPGD
SCHEMBL9134133 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1ALOX15HPGDMAPT
SCHEMBL9132688 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1ALOX15HPGDMAPT
SCHEMBL316419 0.75 LTA4H (0.46) KMT2AMEN1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7901867-B2 Sulphonium salt initiators BASF SE (DE) 2011-03-08 US disclosed
EP-1902019-B1 SULPHONIUM SALT INITIATORS BASF SE (DE) 2010-07-07 EP disclosed
US-20090208872-A1 Sulphonium Salt Initiators BASF SE (DE) 2009-08-20 US disclosed
EP-1902019-A1 SULPHONIUM SALT INITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2008-03-26 EP disclosed
WO-2007003507-A1 SULPHONIUM SALT INITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090208872-A1 Sulphonium Salt Initiators OR10J3, OXSR1, ARSA KMT2A 1924/4885MEN1 3830/4885NPC1 3369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.